About our firm21/01/2021
Bignon Lebray is structuring its Life sciences practice
Bignon Lebray is reinforcing its offer in the field of health law by structuring its Life Sciences law practice through the creation of a dedicated department headed by Barbara Bertholet and Caroline Cazaux, partners of the firm.
The Life Sciences team supports the firm’s clients at every stage of the life of a healthcare product or service: from its conception to its market launch, including the promotion and post-marketing phases. It not only advises its clients on the regulatory and contractual aspects of their projects, but also represents them in Courts as part of litigious matters.
The range of services of the Life Sciences team’s is extensive and covers in particular:
- regulation of health products (human and veterinary drugs, medical devices, in vitro diagnostic devices, blood products, gene therapy products), whether cosmetic and phytosanitary products
- regulation of health activities and players
- regulation of e-health activities.
The Life Sciences team advises international groups, including SMEs and start-ups, with the same objective of providing efficient and pragmatic legal answers adapted to each client’s ecosystem. It assists inter alia several biotechs and medtechs, pharmaceutical laboratories (human and veterinary drugs), medical device and IVDMD manufacturers, home care providers, healthcare professionals and institutions, in the implementation of strategies in connection with regulations, contract negotiations and litigations.
The Life Sciences team works in close collaboration with the Healthcare sector teams to address all the issues faced by the players in this sector, particularly in terms of intellectual property, new technologies and personal data, as well as structuring and capital raising.